Myelodysplastic Syndrome

Myelodysplastic syndromes require integrated review of blood counts, marrow morphology, cytogenetic and molecular features.

Care planning should consider transfusion requirements, infection risk, iron overload, symptom burden and risk category.

Patients benefit from regular monitoring and escalation when cytopenias, blasts or clinical features change.